What's Next For Apricus Biosciences' Vitaros? By: Benzinga via Benzinga February 20, 2018 at 09:39 AM EST Apricus Biosciences Inc (NASDAQ: APRI) receded 67.4 percent Friday and continued down Tuesday after the U.S. Food and Drug ... Read More >>